3Indexed trials
drug · Product Intelligence
Zonisamide
Pipeline Intelligence
Zonisamide: 3 indexed trials, 2 sponsors; 4 linked Orange Book patents and 8 FDA-linked events where matched.
2Sponsors
4Orange Book patent links
8FDA-linked events
Development evidence
NCT00692003Eisai Limited · epilepsyPHASE3
NCT00693017Eisai Limited · epilepsyPHASE3
NCT01140867Eisai Korea Inc. · epilepsyPHASE4
FDA / patent evidence
11478456ZONISADE · app 2142732038-08-18
11529333ZONISADE · app 2142732038-08-18
12491179ZONISADE · app 2142732038-08-18
12685723ZONISADE · app 2142732038-08-18
Regulatory context
FDA_APPROVALZONISADE · 2022-07-15
FDA_APPROVALZONISAMIDE · 2021-01-26
FDA_APPROVALZONISAMIDE · 2007-02-21
FDA_APPROVALZONISAMIDE · 2006-10-16
FDA_APPROVALZONISAMIDE · 2006-07-27
FDA_APPROVALZONISAMIDE · 2006-03-17
FDA_APPROVALZONISAMIDE · 2005-12-22
FDA_APPROVALZONEGRAN · 2003-08-22
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.